spacer
home > pmps > summer 2008 > special dispensation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Special Dispensation

Pressure is increasing on today’s pharmaceutical industry to implement more reliable and consistent safeguards against mistakes in dispensing medication, whether from contamination, mixing up drugs or inappropriate dosing. As a result, pharmaceutical companies are turning to non-destructive testing (NDT) techniques for product and packaging inspection.

A number of these techniques have already been adopted, including the use of optical, infra-red, ultrasound, vacuum decay and x-ray inspection methods. Traditionally, these have primarily been used for batch control through various batch sampling and inspection strategies. However, there is increasing demand for in-line inspection of all products, particularly where they have high commercial value or involve high dosage levels.

Applications for in-line NDT of products are as varied as the products themselves. Typical inspection scenarios may entail: checking fill levels in bottles and tubs of drugs, in liquid, powder, and even tablet forms; checking for missing tablets in blister packs; detecting contaminants (such as metal or glass) in dressings; and checking for correctly assembled devices.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Martin Allen graduated from Nottingham University with an Honours Degree in Geology in 1989 and gained a Doctorate in Engineering in 1993, specialising in image processing and analysis. After two years of developing an advanced document imaging system, Martin joined the software department of OIS Engineering in 1996. Some 11 years later, OIS has become Shaw Inspection Systems, and Martin has become a leading expert in both digital radiography (DR), and computed tomography (CT). He now heads the software department and is responsible for current research and development into both DR and CT.
spacer
Martin Allen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Oxford Genetics licenses SnapFast™ expression vectors to Twist Bioscience

November 16, 2017, Oxford, England and San Francisco, US. – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA. Oxford Genetics will supply Twist Bioscience with its SnapFast™ technology platform to provide a broad range of application-specific expression vectors which Twist Bioscience will use to clone synthesized DNA for its diverse customer base.
More info >>

White Papers

Keeping Abreast of the Competitive Environment in Clinical Development

Thomson Reuters

Strategic management of a therapy area requires hard decisions to be made about which programs to invest in and which to let go. Understanding the rapidly changing competitive environment for your drug candidates is a key input into these decisions. It is easy to lose track of the broader picture when a clinical program is in progress and get blindsided by external events.
More info >>

 
Industry Events

Temperature Controlled Logistics 2018

29 January - 1 February 2018, Twickenham Stadium, London

Each January for the past 16 years, more than 400 senior supply chain, logistics, storage, regulation and quality experts from the pharmaceutical industry have gathered at the TCL Forum for the largest, longest running and most comprehensive cold chain and ambient logistics conference in Europe.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement